trending Market Intelligence /marketintelligence/en/news-insights/trending/-QJfzIqhLd0cFJlmRNvdGg2 content esgSubNav
In This List

Macrocure completes merger with Leap Therapeutics unit

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Macrocure completes merger with Leap Therapeutics unit

Macrocure Ltd. completed its merger with a unit of Cambridge, Mass.-based Leap Therapeutics Inc.

Shareholders of Macrocure will receive 0.1815 common share of Leap per ordinary share of Macrocure canceled, plus cash in place of a fractional common share of Leap.

Trading of Macrocure shares on the Nasdaq Global Market has ceased, and the trading of Leap common stock on the same exchange will begin Jan. 24.